SG Americas Securities’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $362K | Sell |
11,137
-3,383
| -23% | -$110K | ﹤0.01% | 1695 |
|
|
2025
Q1 | $548K | Buy |
14,520
+5,520
| +61% | +$208K | ﹤0.01% | 1527 |
|
|
2024
Q4 | $737K | Sell |
9,000
-530
| -6% | -$43.4K | ﹤0.01% | 894 |
|
|
2024
Q3 | $1.09M | Buy |
9,530
+7,188
| +307% | +$821K | ﹤0.01% | 888 |
|
|
2024
Q2 | $177K | Sell |
2,342
-2,017
| -46% | -$152K | ﹤0.01% | 1970 |
|
|
2024
Q1 | $298K | Buy |
+4,359
| New | +$298K | ﹤0.01% | 1509 |
|
|
2023
Q4 | – | Sell |
-27,980
| Closed | -$1.43M | – | 2974 |
|
|
2023
Q3 | $1.43M | Buy |
+27,980
| New | +$1.43M | 0.02% | 911 |
|
|
2023
Q2 | – | Sell |
-50,626
| Closed | -$1.9M | – | 2599 |
|
|
2023
Q1 | $1.9M | Buy |
50,626
+23,256
| +85% | +$871K | 0.02% | 628 |
|
|
2022
Q4 | $1.31M | Buy |
27,370
+12,098
| +79% | +$580K | 0.02% | 684 |
|
|
2022
Q3 | $367K | Sell |
15,272
-1,073
| -7% | -$25.8K | ﹤0.01% | 1613 |
|
|
2022
Q2 | $356K | Buy |
+16,345
| New | +$356K | ﹤0.01% | 2044 |
|
|
2022
Q1 | – | Sell |
-10,155
| Closed | -$242K | – | 2878 |
|
|
2021
Q4 | $242K | Sell |
10,155
-15,515
| -60% | -$370K | ﹤0.01% | 2320 |
|
|
2021
Q3 | $651K | Buy |
+25,670
| New | +$651K | ﹤0.01% | 2091 |
|
|
2021
Q2 | – | Sell |
-6,714
| Closed | -$133K | – | 2765 |
|
|
2021
Q1 | $133K | Buy |
+6,714
| New | +$133K | ﹤0.01% | 2670 |
|